Assessment of Sarcopenia in Chronic Liver Disease: Indian Perspective
Abhinav Anand, Anoop Saraya – 21 July 2021
Extracorporeal Liver Support: A Bridge to Somewhere
Abraham J. Matar, Ram Subramanian – 21 July 2021
Acute Liver Failure: Indian Perspective
Subrat Kumar Acharya – 21 July 2021
Ethical and Legal Aspects of Pandemics During COVID‐19 and Beyond for the Hepatology Community
Dirk J. Leeuwen – 21 July 2021
Salidroside Activates the AMP‐Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in Mice
Manli Hu, Dingran Zhang, Hongyang Xu, Yan Zhang, Hongjie Shi, Xiaoli Huang, Xinhui Wang, Yan Wu, Zhili Qi – 21 July 2021
Mitochondrial Hepatopathies
Hana Alharbi, Jessica R.C. Priestley, Benjamin J. Wilkins, Rebecca D. Ganetzky – 21 July 2021
Assessment of Sarcopenia in Chronic Liver Disease: Indian Perspective
Abhinav Anand, Anoop Saraya – 21 July 2021
HBV Genotype: A Significant Risk Factor in Determining Which Patients With Chronic HBV Infection Should Undergo Surveillance for HCC: The Hepatitis B Alaska Study
Brian J. McMahon, Leisha D. Nolen, Mary Snowball, Chriss Homan, Susan Negus, Elena Roik, Philip R. Spradling, Dana Bruden – 21 July 2021
Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell–Mediated Antitumor Immunity Through PD‐L1
Noreen Nog‐Qin Chui, Jacinth Wing‐Sum Cheu, Vincent Wai‐Hin Yuen, David Kung‐Chun Chiu, Chi‐Ching Goh, Derek Lee, Misty Shuo Zhang, Irene Oi‐Lin Ng, Carmen Chak‐Lui Wong – 20 July 2021 – Liver cancers consist primarily of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Immune checkpoint inhibitors have emerged as promising therapeutic agents against liver cancers. Programmed cell death protein 1 (PD‐1) is an immunoinhibitory receptor present on T cells that interacts with its ligand programmed death‐ligand 1 (PD‐L1) found on cancer cells.
Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID‐19 Infection
Zobair M. Younossi, Maria Stepanova, Brian Lam, Rebecca Cable, Sean Felix, Thomas Jeffers, Elena Younossi, Huong Pham, Manirath Srishord, Patrick Austin, Michael Estep, Kathy Terra, Carey Escheik, Leyla Avila, Pegah Golabi, Andrej Kolacevski, Andrei Racila, Linda Henry, Lynn Gerber – 20 July 2021 – The impact of the coronavirus disease 2019 (COVID‐19) pandemic among patients with chronic liver disease is unknown.